Galderma receives license for new toxin manufacturing facility in Uppsala

Galderma received a manufacturing license from the Swedish Medical Products Agency for a new state-of-the-art facility at its Center of Excellence in Uppsala, Sweden, to produce its QM1114 liquid botulinum toxin.

“Galderma has received a manufacturing license from the Swedish Medical Products Agency (MPA) for a new state-of-the-art manufacturing facility at the Center of Excellence, located in Uppsala, Sweden.”aestheticsjournal.com

• 1 source
• aestheticsjournal.comGalderma to open new toxin manufacturing facility - Aesthetics JournalKate Byng-HallNov 5, 2019

Summarized from public sources; check the original articles before acting on it.